FDA’s phasing out of Animal Testing and Adoption of New Approach Methodologies
Video Summary
In April 2025, the US Food and Drug Administration (FDA) announced their plan to phase out animal testing and instead favour more effective, human-relevant methods – namely “New Approach Methodologies” (NAMs).
In our latest Q&A interview, Dr Rebbecca Wilcox, Principal Consultant at Scendea, provides several key insights into what this means for drug developers...